Potential for Anti-Chagas Therapies Using Structure-based Drug Design

News   Sep 27, 2017 | Original story from Tokyo Institute of Technology

 
Potential for Anti-Chagas Therapies Using Structure-based Drug Design

Results of the TcSpdSyn-ligand docking analysis. Docking poses of the top five compounds (green: docking results, pink: dcSAM). This simulation was conducted with the TcSpdSyn X-ray structure (PDB ID code: 3BWC). The docking results show that all compounds bind to the putrescine-binding site and that dcSAM binding in its own site. Credit: Yoshino, R. et al. Sci Rep. (2017). doi:10.1038/s41598-017-06411-9

 
 
 

RELATED ARTICLES

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

A Mystery Solved: "Protein Cluedo" Reveals Enzyme Secrets

News

Scientists have used biosensors to solve questions about protein production which might seem familiar to mystery board game enthusiasts.

READ MORE

Cancer Pioneer Employs Physics to Approach Cancer

News

In the cover article of Oncotarget, February 20, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Informatics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE